Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements
This document provides guidance on establishment licensing, product quality and lot release to bring a COVID-19 vaccine to market in Canada.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Similar records